Coromandel International Ltd logo

Coromandel International Ltd

COROMANDEL NSE

Coromandel International Ltd is one of India's leading agri solutions provider. It offers a diverse range of products and services across the farming value chain. It specializes in fertilizers, crop protein, bio pesticide, specialty nutrients, organic fertilizers, etc.[1] Revenue Breakup The company's business is divided among 2 main segments i.e. nutrient and other allied products (~85% of revenues) and crop protection (~15% of revenues).[2] Fertilizers Business The company sells various types of phosphatic fertilizers in the domestic market. It has ~40% share in the unique grade fertilizer sales in India. Overall, it is the 2nd largest phosphatic seller in India and largest single super phosphate (SSP) seller with a market share of ~15%.[3] It has a leading position in the states of Andhra Pradesh and Telangana; India's largest complex-fertiliser markets.[4] Crop Protection Business Under this business, the company sells a wide range of crop protection products under its 60+ brands based portfolio. It is 3rd largest manufacturer of mancozeb globally and exports accounts for ~37% of revenues of the business.[5] Biologicals Business The company has a rich product pipeline with research on compounds from plant extracts and microbial bio-pesticides. It is a leading manufacturer of azadirachtin in the world with ~65% export share. It exports to USA, Canada and Europe.[6]

AI Verdict: BUY Confidence: 7%

Coromandel International offers strong long-term compounding with 10-year stock CAGR of 24% and consistent ROE of 17-22%. Despite a 1-year stock decline of 13% and elevated PE of 32.2x, robust TTM sales growth of 31% and overwhelming analyst consensus (89% Buy) support accumulation at current levels.

Key Fundamentals

MidcapFertilizersChemicals
Market Cap
₹58,519 Cr
Volatility
Moderate
P/E Ratio
30.16
EBITDA
₹3,145 Cr
Return on Equity
17.37%
Debt to Equity
0.06
Book Value
₹425.67
EPS
₹49.55
52W High
₹2,718.9
52W Low
₹1,706.5

Technical Indicators

Key Insights

Weaknesses

2
  • Promoter holding has decreased over last quarter: -0.51%
  • Debtor days have increased from 30.3 to 49.2 days.

Growth Rate

Revenue Growth
28.78% ↗
Net Income Growth
-8.59% ↗
Cash Flow Change
72.56% ↗
ROE
5.41% ↗
ROCE
5.34% ↗
EBITDA Margin (Avg.)
-19.15% ↗

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 3d ago
BUY
Risk medium

Coromandel International offers strong long-term compounding with 10-year stock CAGR of 24% and consistent ROE of 17-22%. Despite a 1-year stock decline of 13% and elevated PE of 32.2x, robust TTM sales growth of 31% and overwhelming analyst consensus (89% Buy) support accumulation at current levels.

Bull Case 8
  • Exceptional long-term wealth creation with 10-year stock CAGR of 24%, significantly outperforming broader market indices
  • TTM revenue growth of 31% signals strong demand momentum in fertilizers and crop protection segments
  • Overwhelming analyst consensus with 88.89% Buy ratings (8 out of 9 analysts) and zero Sell recommendations
  • Consistent return on equity averaging 17-22% over 3-10 year periods, indicating efficient capital deployment
  • Compounded sales growth of 17% over 5 years demonstrates sustained business scalability
  • TTM profit growth of 16% shows earnings continue to expand despite margin pressures in commodity business
  • Market cap of Rs 59,702 Cr provides institutional-grade liquidity and index inclusion benefits
  • 10-year compounded profit growth of 19% demonstrates long-cycle earnings resilience across commodity cycles
Bear Case 8
  • PE ratio of 32.2x is elevated for a commodities business, pricing in significant growth expectations
  • 1-year stock return of -13% indicates near-term price weakness and potential de-rating risk
  • Debtor days increased from 30.3 to 49.2 days, a 62% deterioration signaling working capital stress or channel credit extension
  • 3-year compounded profit growth of 0% suggests earnings stagnation over the medium term despite revenue growth
  • Promoter holding decreased by 0.51% in last quarter, potentially signaling insider caution
  • Dividend yield of only 0.53% offers minimal income support during periods of capital depreciation
  • 3-year compounded sales growth of just 2% indicates revenue plateaued before recent TTM spike, raising sustainability questions
  • Price-to-book ratio of 4.86x leaves limited margin of safety for a cyclical commodity-linked business

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 14h ago
Neutral 1
  • Special window for share transfers Jun 10

    Coromandel opened a special window until February 4, 2027, for transfer and dematerialisation of physical securities purchased before April 1, 2019. Transferred shares will be locked in for one year.

TL;DR: Limited news flow for Coromandel this period, with only a routine administrative update on physical share transfers. No material headwinds or positive catalysts emerged. The lack of news suggests stable operations with no immediate risks or growth triggers visible from recent coverage.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
5,476
5,693
6,988
5,464
3,913
4,729
7,433
6,935
4,988
7,042
9,654
8,779
6,004
Expenses
5,089
4,988
5,933
5,115
3,650
4,238
6,471
6,222
4,579
6,260
8,508
7,980
5,516
Operating Profit
387
706
1,055
349
263
490
962
713
409
782
1,147
800
488
OPM %
7%
12%
15%
6%
7%
10%
13%
10%
8%
11%
12%
9%
8%
Other Income
47
44
45
59
84
54
65
114
473
84
116
83
-6
Interest
52
41
46
38
62
57
66
73
66
68
102
84
89
Depreciation
45
48
54
64
63
65
69
71
85
121
102
147
165
PBT
337
661
1,000
306
222
422
892
683
731
677
1,059
653
228
Tax %
27%
25%
25%
25%
26%
27%
26%
26%
21%
26%
25%
25%
50%
Net Profit
246
494
755
228
164
309
659
508
578
502
793
488
115
EPS in Rs
8.38
16.8
25.71
7.85
5.45
10.56
22.55
17.37
19.67
17.13
27.31
17.15
4.74
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
11,306
11,481
10,031
11,083
13,225
13,137
14,182
19,111
29,628
22,058
24,085
31,480
Expenses
10,450
10,712
9,048
9,822
11,775
11,400
12,193
16,954
26,726
19,678
21,508
28,264
Operating Profit
856
769
983
1,261
1,450
1,737
1,989
2,156
2,902
2,380
2,577
3,216
OPM %
8%
7%
10%
11%
11%
13%
14%
11%
10%
11%
11%
10%
Other Income
50
87
54
55
8
35
76
141
171
223
703
277
Interest
210
221
224
178
251
235
106
75
190
187
262
343
Depreciation
105
106
101
99
114
158
173
173
182
229
290
534
PBT
592
529
712
1,038
1,093
1,379
1,786
2,050
2,701
2,188
2,728
2,617
Tax %
32%
32%
33%
33%
34%
23%
26%
25%
25%
25%
25%
27%
Net Profit
402
357
477
691
720
1,065
1,329
1,528
2,013
1,641
2,055
1,898
EPS in Rs
13.8
12.27
16.35
23.64
24.63
36.36
45.3
52.08
68.46
55.78
70.14
66.31
Div. Payout %
33%
33%
31%
27%
26%
33%
26%
23%
18%
11%
21%
17%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
29
29
29
29
29
29
29
29
29
29
29
30
Reserves
2,173
2,605
2,862
2,867
3,329
4,288
5,121
6,329
7,878
9,390
11,058
12,528
Borrowings
2,288
2,677
2,228
2,728
2,954
2,019
385
395
393
492
780
1,506
Other Liabilities
3,872
3,871
3,526
4,224
4,261
3,812
3,360
4,532
5,934
5,933
7,049
10,439
Total Liabilities
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,503
Fixed Assets
1,380
1,320
1,328
1,327
1,309
2,032
2,015
2,092
2,200
3,112
4,139
6,790
CWIP
46
42
22
48
191
65
90
141
399
235
396
296
Investments
352
477
388
221
201
211
214
243
287
854
1,031
2,044
Other Assets
6,583
7,343
6,907
8,252
8,873
7,840
6,576
8,809
11,348
11,644
13,351
15,374
Total Assets
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,503
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
86
18
915
263
526
1,862
4,150
2,078
591
1,428
2,464
1,558
Investing
-216
-61
-79
38
-597
-220
-1,245
-1,622
640
-1,333
-2,638
-559
Financing
-64
8
-864
-1
-244
-1,723
-2,263
-443
-543
-363
-698
-831
Net Cash Flow
-194
-34
-28
300
-314
-82
642
14
688
-269
-872
168
Free Cash Flow
-6
-89
834
134
255
1,606
3,958
1,801
22
910
2,030
22
CFO/OP
27
25
120
49
62
128
232
119
45
86
123
71
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47
52
59
52
50
48
14
5
7
23
19
49
Inventory Days
96
98
88
109
127
109
98
94
69
102
98
111
Days Payable
131
135
150
162
147
135
110
100
83
119
123
136
Cash Conversion Cycle
12
15
-3
-2
30
22
2
-1
-7
6
-7
24
Working Capital Days
11
24
40
27
42
65
64
41
37
46
28
57
ROCE %
19%
15%
18%
23%
23%
26%
32%
35%
38%
26%
23%
23%

Shareholding Pattern

As of Mar 2026
Promoters 56.35%
DIIs 18.20%
FIIs 13.02%
Public 7.72%
Others 4.70%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
57.56%
57.56%
57.54%
57.53%
57.53%
57.48%
57.44%
57.41%
57.41%
57.40%
57.33%
57.33%
57.32%
57.31%
57.17%
56.97%
56.96%
56.90%
56.88%
56.86%
56.35%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
7.19%
0.00%
7.34%
7.52%
7.79%
8.33%
10.61%
14.29%
14.51%
13.80%
13.02%
DIIs
16.59%
18.02%
15.38%
16.09%
16.39%
15.52%
18.69%
18.03%
18.90%
20.63%
21.14%
19.63%
20.67%
20.82%
21.26%
21.02%
18.98%
15.86%
15.79%
16.70%
18.20%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
9.20%
8.64%
8.93%
8.78%
9.37%
9.50%
9.42%
9.60%
9.66%
9.72%
9.59%
9.81%
9.69%
9.36%
8.77%
8.81%
8.63%
8.27%
8.18%
7.93%
7.72%
Others
16.66%
15.78%
18.15%
17.61%
16.72%
17.50%
14.44%
14.96%
14.03%
12.25%
4.75%
13.24%
4.97%
5.00%
5.01%
4.87%
4.82%
4.68%
4.64%
4.71%
4.70%
No. of Shareholders
1,01,161
96,227
1,14,352
1,12,677
1,15,440
1,39,667
1,42,752
1,33,758
1,32,103
1,32,344
1,23,639
1,26,628
1,36,412
1,36,497
1,41,349
1,40,959
1,43,560
1,43,623
1,45,222
1,34,655
1,37,335

Documents

Frequently Asked Questions about Coromandel International Ltd

What does Coromandel International Ltd do?
Coromandel International Ltd is one of India's leading agri solutions provider. It offers a diverse range of products and services across the farming value chain. It specializes in fertilizers, crop protein, bio pesticide, specialty nutrients, organic fertilizers, etc.[1] Revenue Breakup The comp...
Where is Coromandel International Ltd (COROMANDEL) listed?
Coromandel International Ltd is listed on the Indian stock exchanges. It is listed on NSE: COROMANDEL and BSE: 506395. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Coromandel International Ltd belong to?
Coromandel International Ltd operates in the Commodities sector within the Fertilizers & Agrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Coromandel International Ltd?
Coromandel International Ltd has a market capitalisation of approximately ₹58519.10 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Coromandel International Ltd?
The Price-to-Earnings (PE) ratio of Coromandel International Ltd is 30.16. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Coromandel International Ltd?
Over the past 52 weeks, Coromandel International Ltd has traded between a low of ₹1,706.5 and a high of ₹2,718.9. This range helps investors understand the stock's price volatility and recent trading levels.
Does Coromandel International Ltd pay dividends?
Yes, Coromandel International Ltd has a dividend yield of 0.55%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Coromandel International Ltd?
Coromandel International Ltd has a Return on Equity (ROE) of 17.37%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Coromandel International Ltd on Tapetide?
On Tapetide, you can view Coromandel International Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Coromandel International Ltd is one of India's leading agri solutions provider. It offers a diverse range of products and services across the farming value chain. It specializes in fertilizers, crop protein, bio pesticide, specialty nutrients, organic fertilizers, etc.[1] Revenue Breakup The company's business is divided among 2 main segments i.e. nutrient and other allied products (~85% of revenues) and crop protection (~15% of revenues).[2] Fertilizers Business The company sells various types of phosphatic fertilizers in the domestic market. It has ~40% share in the unique grade fertilizer sales in India. Overall, it is the 2nd largest phosphatic seller in India and largest single super phosphate (SSP) seller with a market share of ~15%.[3] It has a leading position in the states of Andhra Pradesh and Telangana; India's largest complex-fertiliser markets.[4] Crop Protection Business Under this business, the company sells a wide range of crop protection products under its 60+ brands based portfolio. It is 3rd largest manufacturer of mancozeb globally and exports accounts for ~37% of revenues of the business.[5] Biologicals Business The company has a rich product pipeline with research on compounds from plant extracts and microbial bio-pesticides. It is a leading manufacturer of azadirachtin in the world with ~65% export share. It exports to USA, Canada and Europe.[6]

Website coromandel.biz
CEO Mr. Arun Alagappan
Employees 5,540
Listed 1995-05-31
Face Value ₹ 1
Issued Size 29,49,95,409

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List